Physician profile
William Adkins
NPI 1972568822
$2,245.92
in general payments reported to CMS, 2019-2025
28 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $288 · 2021: $459 · 2022: $418 · 2023: $307 · 2024: $365 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $361.63 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $307.03 | 2019-2023 | Ubrelvy |
| Sanofi-Aventis U.S. LLC | $268.05 | 2019-2023 | |
| Myovant Sciences INC. | $153.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $111.88 | 2025 | Airsupra |
| Lilly USA, LLC | $89.94 | 2024 | Zepbound |
| Exeltis, USA INC. | $87.74 | 2020-2022 | |
| Shield Therapeutics INC | $87.25 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $76.41 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $73.21 | 2019-2022 | |
| Minerva Surgical, INC | $72.99 | 2019-2022 | |
| Pfizer INC. | $72.26 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $70.73 | 2019-2021 | |
| Organon LLC | $55.55 | 2021-2022 | |
| Hologic Sales and Service, LLC | $45.66 | 2020-2023 | Aptima |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $43.66 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $41.43 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Amag Pharmaceuticals, INC. | $31.76 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.56 | 2020-2021 | |
| Agile Therapeutics, INC. | $28.07 | 2021-2022 | |
| Amgen INC. | $27.22 | 2024 | Prolia, Evenity |
| Teleflex LLC | $24.15 | 2022 | |
| Mayne Pharma Commercial LLC | $21.82 | 2022 | |
| Aspira Women'S Health INC | $17.43 | 2023 | Ova1 |
| Evofem Biosciences, INC. | $16.75 | 2021 | |
| Millicent US INC | $13.97 | 2025 | Intrarosa, Femring |
| Coopersurgical, INC. | $11.41 | 2020 | |
| Meditrina | $6.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.